Support In Place For This Biotech Out-Performer

Published 09/25/2015, 10:45 AM
Updated 07/09/2023, 06:31 AM
IBB
-
XBI
-

When it comes to Bio Tech ETFs, performance over the past year has varied greatly. The chart below looks at iShares Nasdaq Biotechnology (NASDAQ:IBB) and SPDR S&P Biotech (NYSE:XBI), both Biotech ETF’s. As you can see, XBI is doing much better in 2015 than IBB, up almost 100% more.

iShares Nasdaq Biotechnology Vs. SPDR S&P Biotech

Below looks at the patterns in IBB and XBI, which do have different patterns to say the least!

IBB Breaks 4-Year Rising Support

The chart of IBB on the left reflects a 4-year rising support line was broken and kissed as resistance at the red arrow above.

XBI on the other had, remains well inside of a 4-year rising channel.

These Biotech ETF’s are not built the same and the leading performer of the two remains inside of this rising channel. I will be concerned for this sector and the broad markets if XBI breaks below support.

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.